Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options

Fabian Lang; Lydia Wunderle; Heike Pfeifer; Susanne Schnittger; Gesine Bug; Oliver G. Ottmann

doi:10.12659/AJCR.904956

16 October 2017 : Case report Germany

Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options

Rare coexistence of disease or pathology

Fabian Lang^{ABCDEF 1*}, Lydia Wunderle^{BDE 1}, Heike Pfeifer^{C 1}, Susanne Schnittger^{C 2}, Gesine Bug^{BE 1}, Oliver G. Ottmann^{ABCDEF 3}

DOI: 10.12659/AJCR.904956

Am J Case Rep 2017; 18:1099-1109

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Back to the Article

Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options

Your Privacy